Randomized control trial

Last updated: November 01, 2022

Randomized control trial

Watch later

Watch later

Approach to hypertension: Clinical sciences
Chest X-ray interpretation: Clinical sciences
Acute mesenteric ischemia: Clinical sciences
Aortic dissection: Clinical sciences
Cardiac tamponade: Clinical sciences
Congestive heart failure: Clinical sciences
Hypovolemic shock: Clinical sciences
Infectious endocarditis: Clinical sciences
Mitral stenosis: Clinical sciences
Pericarditis: Clinical sciences
Peripheral arterial disease and ulcers: Clinical sciences
Right heart failure: Clinical sciences
Temporal arteritis: Clinical sciences
Valvular insufficiency (regurgitation): Clinical sciences
Approach to hyperthyroidism and thyrotoxicosis: Clinical sciences
Approach to hypothyroidism: Clinical sciences
Approach to hypoglycemia: Clinical sciences
Acute pancreatitis: Clinical sciences
Cushing syndrome and Cushing disease: Clinical sciences
Adrenal insufficiency: Clinical sciences
Diabetes mellitus (Type 1): Clinical sciences
Diabetes mellitus (Type 2): Clinical sciences
Hyperosmolar hyperglycemic state: Clinical sciences
Graves disease: Clinical Sciences
Diabetic ketoacidosis: Clinical sciences
Hashimoto thyroiditis: Clinical sciences
Hyperparathyroidism: Clinical sciences
Primary aldosteronism (hyperaldosteronism): Clinical sciences
Syndrome of inappropriate antidiuretic hormone secretion: Clinical sciences
Approach to periumbilical and lower abdominal pain: Clinical sciences
Acetaminophen (Paracetamol) toxicity: Clinical sciences
Appendicitis: Clinical sciences
Cholecystitis: Clinical sciences
Choledocholithiasis and cholangitis: Clinical sciences
Diverticulitis: Clinical sciences
Hepatic encephalopathy: Clinical sciences
Hepatitis A and E: Clinical sciences
Hepatitis B: Clinical sciences
Hepatitis C: Clinical sciences
Ileus: Clinical sciences
Irritable bowel syndrome: Clinical sciences
Large bowel obstruction: Clinical sciences
Peptic ulcer disease: Clinical sciences
Small bowel obstruction: Clinical sciences
Approach to bleeding disorders (coagulopathy): Clinical sciences
Approach to bleeding disorders (thrombocytopenia): Clinical sciences
Approach to bleeding disorders (platelet dysfunction): Clinical sciences
Approach to hypercoagulable disorders: Clinical sciences
Approach to leukemia: Clinical sciences
Iron deficiency anemia: Clinical sciences
Sickle cell disease: Clinical sciences
Vitamin B12 deficiency: Clinical sciences
Basal cell carcinoma: Clinical sciences
Burns: Clinical sciences
Lyme disease: Clinical sciences
Melanoma: Clinical sciences
Necrotizing soft tissue infections: Clinical sciences
Pressure-induced skin and soft tissue injury: Clinical sciences
Approach to lymphoma: Clinical sciences
Approach to hallucinogen, inhalant, and cannabis use, intoxication, and overdose: Clinical sciences
Approach to stimulant use, intoxication, and overdose: Clinical sciences
Approach to trauma and stressor-related disorders: Clinical sciences
Opioid intoxication and overdose: Clinical sciences
Bipolar I, bipolar II, and cyclothymic disorder: Clinical sciences
Opioid use disorder: Clinical sciences
Substance use disorder: Clinical sciences
Approach to a fever in the returned traveler: Clinical sciences
Approach to a postoperative fever: Clinical sciences
Approach to acid-base disorders: Clinical sciences
Approach to a fever: Clinical sciences
Approach to hypercalcemia: Clinical sciences
Approach to hyperkalemia: Clinical sciences
Approach to hyponatremia: Clinical sciences
Approach to metabolic alkalosis: Clinical sciences
Approach to nosocomial infections: Clinical sciences
Approach to metabolic acidosis: Clinical sciences
Approach to hypernatremia: Clinical sciences
Approach to respiratory acidosis: Clinical sciences
Approach to respiratory alkalosis: Clinical sciences
Infectious mononucleosis: Clinical sciences
Obesity and metabolic syndrome: Clinical sciences
Systemic lupus erythematosus: Clinical sciences
Tuberculosis (extrapulmonary and latent): Clinical sciences
Approach to unsteadiness, gait disturbance, or falls: Clinical sciences
Myasthenia gravis: Clinical sciences
Osteoarthritis: Clinical sciences
Septic arthritis: Clinical sciences
Spinal fractures: Clinical sciences
Rheumatoid arthritis: Clinical sciences
Spinal infection and abscess: Clinical sciences
Approach to aphasia: Clinical sciences
Approach to blunt traumatic cervical spine injuries: Clinical sciences
Approach to differentiating lesions (brainstem): Clinical sciences
Approach to differentiating lesions (cerebral cortical and subcortical structures): Clinical sciences
Approach to differentiating lesions (cerebellum): Clinical sciences
Approach to differentiating lesions (motor neuron): Clinical sciences
Approach to differentiating lesions (nerve root, plexus, and peripheral nerve): Clinical sciences
Approach to differentiating lesions (spinal cord): Clinical sciences
Approach to dysarthria or dysphagia: Clinical sciences
Approach to headache or facial pain: Clinical sciences
Approach to epilepsy: Clinical sciences
Approach to increased intracranial pressure: Clinical sciences
Approach to traumatic brain injury: Clinical sciences
Acute stroke (ischemic or hemorrhagic) or TIA: Clinical sciences
Delirium: Clinical sciences
Brain death: Clinical sciences
Diabetes insipidus: Clinical sciences
Guillain-Barré syndrome: Clinical sciences
Meningitis and brain abscess: Clinical sciences
Subarachnoid hemorrhage: Clinical sciences
Approach to lower limb edema: Clinical sciences
Approach to vasculitis: Clinical sciences
Deep vein thrombosis: Clinical sciences
Venous insufficiency and ulcers: Clinical sciences
Sexually transmitted infection screening (GYN): Clinical sciences
Approach to vaginal discharge: Clinical sciences
Chlamydia trachomatis infection: Clinical sciences
Neisseria gonorrhoeae infection: Clinical sciences
Pelvic inflammatory disease: Clinical sciences
Approach to dyspnea: Clinical sciences
Approach to pneumoperitoneum and peritonitis (perforated viscus): Clinical sciences
Acute respiratory distress syndrome: Clinical sciences
Asthma in pregnancy: Clinical sciences
Airway obstruction: Clinical sciences
Atelectasis: Clinical sciences
Asthma: Clinical sciences
Community-acquired pneumonia: Clinical sciences
Empyema: Clinical sciences
Hospital-acquired and ventilator-associated pneumonia: Clinical sciences
Influenza: Clinical sciences
Pleural effusion: Clinical sciences
Pulmonary embolism: Clinical sciences
Pneumothorax: Clinical sciences
Upper respiratory tract infections: Clinical sciences
Tuberculosis (pulmonary): Clinical sciences
Approach to acute kidney injury: Clinical sciences
Catheter-associated urinary tract infection: Clinical sciences
Intrinsic acute kidney injury (glomerular causes): Clinical sciences
Chronic kidney disease: Clinical sciences
Intrinsic acute kidney injury (non-glomerular causes): Clinical sciences
Lower urinary tract infection: Clinical sciences
Postrenal acute kidney injury: Clinical sciences
Pyelonephritis: Clinical sciences
Prerenal acute kidney injury: Clinical sciences
Asthma: Information for patients and families (The Primary School)
Food allergies and EpiPens: Information for patients and families (The Primary School)
Empathetic listening for clinicians
Shared decision-making
Implicit bias
The do's and don'ts of patient care
Cardiovascular disease screening: Clinical sciences
Essential hypertension: Clinical sciences
Approach to a murmur (pediatrics): Clinical sciences
Carotid artery stenosis screening: Clinical sciences
Acute rheumatic fever and rheumatic heart disease: Clinical sciences
Randomized control trial
Clinical trials
Study designs
Bias in performing clinical studies
Problem-based learning
Sample size
Information bias
Selection bias
Case-control study
Cohort study
Hypothesis testing: One-tailed and two-tailed tests
Correlation
Paired t-test
Types of data
Bias in interpreting results of clinical studies
Two-sample t-test
The role of the kidney in acid-base balance
Anatomy of the glossopharyngeal nerve (CN IX)
Anticoagulants: Warfarin
Class I antiarrhythmics: Sodium channel blockers
Hepatitis A and Hepatitis E virus
Class IV antiarrhythmics: Calcium channel blockers and others
Anatomy clinical correlates: Oculomotor (CN III), trochlear (CN IV) and abducens (CN VI) nerves
Anatomy of the facial nerve (CN VII)
Anatomy of the vestibulocochlear nerve (CN VIII)
Anatomy clinical correlates: Glossopharyngeal (CN IX), vagus (X), spinal accessory (CN XI) and hypoglossal (CN XII) nerves
Anatomy clinical correlates: Facial (CN VII) and vestibulocochlear (CN VIII) nerves
Anatomy of the trigeminal nerve (CN V)
Anatomy of the spinal accessory (CN XI) and hypoglossal (CN XII) nerves
Anatomy of the vagus nerve (CN X)
Definitions of acids and bases
Anatomy clinical correlates: Trigeminal nerve (CN V)
Kidney stones: Pathology review
Meningitis
Cellulitis and erysipelas: Clinical sciences
Sepsis: Clinical sciences
Bacterial vaginosis: Clinical sciences
Aspiration pneumonia and pneumonitis: Clinical sciences
Clostridioides difficile infection: Clinical sciences

Transcript

Watch video only

Randomized controlled trials or RCTs are a type of study design that’s often used to figure out if there’s a causal relationship between an exposure and an outcome.

For example, let’s say we want to find out if a newly discovered drug, let’s call it Drug A, can prevent migraines for up to a year.

In this example, Drug A is the exposure and having a migraine is the outcome.

In the most basic randomized controlled trial, the sample population might be randomly split into two treatment groups, an exposure group that receives Drug A, and a control group that receives a placebo.

The placebo looks and tastes like Drug A but is completely harmless and ineffective - like a tiny capsule filled with water.

After both groups get their treatments, researchers would compare the number of individuals in each group who got migraines over the next year.

Typically, the goal of a randomized controlled trial is to figure out if the intervention can help some target population - usually that’s just people in the general population.

That means that it’s important to perform the trial on individuals that accurately represent the general population.

In other words, the sample population should be similar to the general population.

For example, if researchers want to find out if Drug A helps prevent migraines in women, then women are the target population.

And the randomized control trial should be done on women rather than being done on men.

Furthermore, if the goal is to use Drug A for women around the world, then the sample population shouldn’t just include women living in Vancouver, British Columbia.

Instead it should include women of all ages, races, and socioeconomic statuses from around the world.

If the sample population and that target population are really similar, then the randomized controlled trial has high external validity, meaning that any conclusions made about the sample population can be applied to the target population, which is good news for the manufacturer of Drug A and hopefully means fewer headaches for women around the world!

Now, to make the sample population represents the target population, one tool that can be used is randomization, meaning that individuals get selected to enter the study through a process of chance.

To show how that works, let’s say they put the names of every women in the target population into a brown paper bag, a big brown paper bag.

So that’s 3.5 billion names in that bag - probably with a number of repeats.

Then let’s say that you choose a thousand names out of the bag to include in the study - either by simply picking them or by using a computer program to make sure that it’s truly by chance.

That’s randomization.

Randomization minimizes the chance of selection bias, which is when researchers decide for themselves who to include in a research study.

For example, the researchers might choose slightly older women with a median age of 60, simply because they have more time and are more willing to join the study.

Now, as it turns out the median age of a woman around the world is 30.

So, in this example, the study results wouldn’t necessarily apply to the target population, and the study would have low external validity.

After figuring out who will participate in the study - the sample population - the next step is to divide the participants into treatment groups.

This is done by random allocation, where an individual is assigned to a treatment group once again by chance.

The goal is to make sure that the treatment groups - whether there are two like in our study or many different treatment groups - all have similar characteristics.

Key Takeaways

A randomized controlled trial (RCT) is a type of experimental research design in which participants are randomly assigned to one of two or more groups, such as a treatment group or a control group. The goal is to determine the effectiveness of an intervention or treatment by comparing the outcomes between the groups. Patients who are in a control group receive a placebo instead of the active treatment. The groups are then followed over time to see if there is a difference in the outcome measures (such as symptoms, quality of life, or survival) between the groups.